Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Healing bone lesion defects using injectable CaSO4 /CaPO4 -TCP bone graft substitute compared to cancellous allograft bone chips in a canine model.

Hall DJ, Turner TM, Urban RM.

J Biomed Mater Res B Appl Biomater. 2019 Feb;107(2):408-414. doi: 10.1002/jbm.b.34132. Epub 2018 Apr 16.

PMID:
29663638
2.

GB virus type C E2 protein inhibits human immunodeficiency virus type 1 Gag assembly by downregulating human ADP-ribosylation factor 1.

Wang C, Timmons CL, Shao Q, Kinlock BL, Turner TM, Iwamoto A, Zhang H, Liu H, Liu B.

Oncotarget. 2015 Dec 22;6(41):43293-309. doi: 10.18632/oncotarget.6537.

3.

Nanoscale surface modification by anodic oxidation increased bone ingrowth and reduced fibrous tissue in the porous coating of titanium-alloy femoral hip arthroplasty implants.

Hall DJ, Urban RM, Pourzal R, Turner TM, Skipor AK, Jacobs JJ.

J Biomed Mater Res B Appl Biomater. 2017 Feb;105(2):283-290. doi: 10.1002/jbm.b.33554. Epub 2015 Oct 19.

PMID:
26477322
4.

HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity.

Wang Y, Kinlock BL, Shao Q, Turner TM, Liu B.

Retrovirology. 2014 Oct 11;11:89. doi: 10.1186/s12977-014-0089-5.

5.

Transcytosis of HIV-1 through vaginal epithelial cells is dependent on trafficking to the endocytic recycling pathway.

Kinlock BL, Wang Y, Turner TM, Wang C, Liu B.

PLoS One. 2014 May 15;9(5):e96760. doi: 10.1371/journal.pone.0096760. eCollection 2014.

6.

A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV.

Turner TM, Jones LP, Tompkins SM, Tripp RA.

J Virol. 2013 Oct;87(19):10792-804. doi: 10.1128/JVI.01724-13. Epub 2013 Jul 31.

7.

Implantation of a titanium partial limb prosthesis in a white-naped crane (Grus vipio).

Rush EM, Turner TM, Montgomery R, Ogburn AL, Urban RM, Sidebothum C, LaVasser A.

J Avian Med Surg. 2012 Sep;26(3):167-75.

PMID:
23156979
8.

Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature.

Reilly RM, McDonald HA, Puttfarcken PS, Joshi SK, Lewis L, Pai M, Franklin PH, Segreti JA, Neelands TR, Han P, Chen J, Mantyh PW, Ghilardi JR, Turner TM, Voight EA, Daanen JF, Schmidt RG, Gomtsyan A, Kort ME, Faltynek CR, Kym PR.

J Pharmacol Exp Ther. 2012 Aug;342(2):416-28. doi: 10.1124/jpet.111.190314. Epub 2012 May 8.

PMID:
22570364
9.

Racism, health status, and birth outcomes: results of a participatory community-based intervention and health survey.

Carty DC, Kruger DJ, Turner TM, Campbell B, DeLoney EH, Lewis EY.

J Urban Health. 2011 Feb;88(1):84-97. doi: 10.1007/s11524-010-9530-9.

10.

A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.

Gao Y, Carr RA, Spence JK, Wang WW, Turner TM, Lipari JM, Miller JM.

Mol Pharm. 2010 Oct 4;7(5):1516-26. doi: 10.1021/mp100157s. Epub 2010 Aug 17.

PMID:
20715778
11.

A journey through joy and grief.

Turner TM.

Nurs Womens Health. 2010 Aug;14(4):348, 346-7. doi: 10.1111/j.1751-486X.2010.01567.x. No abstract available.

PMID:
20691014
12.

Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists.

Perner RJ, Koenig JR, Didomenico S, Gomtsyan A, Schmidt RG, Lee CH, Hsu MC, McDonald HA, Gauvin DM, Joshi S, Turner TM, Reilly RM, Kym PR, Kort ME.

Bioorg Med Chem. 2010 Jul 1;18(13):4821-9. doi: 10.1016/j.bmc.2010.04.099. Epub 2010 May 10.

PMID:
20570528
13.

Looking forward at veterinary total joint arthroplasty.

Turner TM.

Vet Surg. 2009 Jul;38(5):553-4. doi: 10.1111/j.1532-950X.2009.00558.x. No abstract available.

PMID:
19573055
14.

Vertebroplasty comparing injectable calcium phosphate cement compared with polymethylmethacrylate in a unique canine vertebral body large defect model.

Turner TM, Urban RM, Singh K, Hall DJ, Renner SM, Lim TH, Tomlinson MJ, An HS.

Spine J. 2008 May-Jun;8(3):482-7. doi: 10.1016/j.spinee.2006.12.007. Epub 2007 Mar 5.

PMID:
18455113
15.

Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavir.

Kempf DJ, Klein C, Chen HJ, Klein LL, Yeung C, Randolph JT, Lau YY, Chovan LE, Guan Z, Hernandez L, Turner TM, Dandliker PJ, Marsh KC.

Antivir Chem Chemother. 2007;18(3):163-7.

PMID:
17626600
16.
17.

Increased bone formation using calcium sulfate-calcium phosphate composite graft.

Urban RM, Turner TM, Hall DJ, Inoue N, Gitelis S.

Clin Orthop Relat Res. 2007 Jun;459:110-7.

PMID:
17415007
18.

Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists.

Xin Z, Serby MD, Zhao H, Kosogof C, Szczepankiewicz BG, Liu M, Liu B, Hutchins CW, Sarris KA, Hoff ED, Falls HD, Lin CW, Ogiela CA, Collins CA, Brune ME, Bush EN, Droz BA, Fey TA, Knourek-Segel VE, Shapiro R, Jacobson PB, Beno DW, Turner TM, Sham HL, Liu G.

J Med Chem. 2006 Jul 27;49(15):4459-69.

PMID:
16854051
19.

2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.

Serby MD, Zhao H, Szczepankiewicz BG, Kosogof C, Xin Z, Liu B, Liu M, Nelson LT, Kaszubska W, Falls HD, Schaefer V, Bush EN, Shapiro R, Droz BA, Knourek-Segel VE, Fey TA, Brune ME, Beno DW, Turner TM, Collins CA, Jacobson PB, Sham HL, Liu G.

J Med Chem. 2006 Apr 20;49(8):2568-78.

PMID:
16610800
20.

Effects of implant material and plate design on tendon function and morphology.

Cohen MS, Turner TM, Urban RM.

Clin Orthop Relat Res. 2006 Apr;445:81-90.

PMID:
16601410
21.

Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model.

Sumner DR, Turner TM, Urban RM, Virdi AS, Inoue N.

J Bone Joint Surg Am. 2006 Apr;88(4):806-17.

PMID:
16595471
22.

Effect of hip hemiarthroplasty on articular cartilage and bone in a canine model.

Minihane KP, Turner TM, Urban RM, Williams JM, Thonar EJ, Sumner DR.

Clin Orthop Relat Res. 2005 Aug;(437):157-63.

PMID:
16056044
23.

Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets.

Turner TM, Urban RM, Hall DJ, Chye PC, Segreti J, Gitelis S.

Clin Orthop Relat Res. 2005 Aug;(437):97-104.

PMID:
16056033
24.

Depressed bone mineralization following high dose TGF-beta1 application in an orthopedic implant model.

Broderick E, Infanger S, Turner TM, Sumner DR.

Calcif Tissue Int. 2005 May;76(5):379-84. Epub 2005 Apr 21.

PMID:
15834504
25.

Animal models relevant to cementless joint replacement.

Sumner DR, Turner TM, Urban RM.

J Musculoskelet Neuronal Interact. 2001 Jun;1(4):333-45.

28.

An injectable calcium sulfate-based bone graft putty using hydroxypropylmethylcellulose as the plasticizer.

Urban RM, Turner TM, Hall DJ, Infanger SI, Cheema N, Lim TH, Richelsoph K.

Orthopedics. 2004 Jan;27(1 Suppl):s155-9.

PMID:
14763550
29.

Effects of altered crystalline structure and increased initial compressive strength of calcium sulfate bone graft substitute pellets on new bone formation.

Urban RM, Turner TM, Hall DJ, Infanger SI, Cheema N, Lim TH, Moseley J, Carroll M, Roark M.

Orthopedics. 2004 Jan;27(1 Suppl):s113-8.

PMID:
14763540
30.

Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model.

Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM.

J Orthop Res. 2004 Jan;22(1):58-65.

31.

The use of acellular dermal matrix as a scaffold for periosteum replacement.

Beniker D, McQuillan D, Livesey S, Urban RM, Turner TM, Blum B, Hughes K, Haggard WO.

Orthopedics. 2003 May;26(5 Suppl):s591-6.

PMID:
12755232
32.

Healing of large defects treated with calcium sulfate pellets containing demineralized bone matrix particles.

Urban RM, Turner TM, Hall DJ, Infanger S, Cheema N, Lim TH.

Orthopedics. 2003 May;26(5 Suppl):s581-5.

PMID:
12755230
33.

Resorption evaluation of a large bolus of calcium sulfate in a canine medullary defect.

Turner TM, Urban RM, Gitelis S, Haggard WO, Richelsoph K.

Orthopedics. 2003 May;26(5 Suppl):s577-9.

PMID:
12755229
34.

Osseous healing using injectable calcium sulfate-based putty for the delivery of demineralized bone matrix and cancellous bone chips.

Turner TM, Urban RM, Hall DJ, Infanger S, Gitelis S, Petersen DW, Haggard WO.

Orthopedics. 2003 May;26(5 Suppl):s571-5.

PMID:
12755228
35.
36.

Aging does not lessen the effectiveness of TGFbeta2-enhanced bone regeneration.

Sumner DR, Turner TM, Cohen M, Losavio P, Urban RM, Nichols EH, McPherson JM.

J Bone Miner Res. 2003 Apr;18(4):730-6.

37.

The practical synthesis of a novel and highly potent analogue of bryostatin.

Wender PA, Baryza JL, Bennett CE, Bi FC, Brenner SE, Clarke MO, Horan JC, Kan C, LacĂ´te E, Lippa B, Nell PG, Turner TM.

J Am Chem Soc. 2002 Nov 20;124(46):13648-9.

PMID:
12431074
39.

The Synthesis and Evaluation of a Solution-Phase Indexed Combinatorial Library of Non-natural Polyenes for Multidrug Resistance Reversal.

Andrus MB, Turner TM, Asgari D, Li W.

J Org Chem. 1999 Apr 30;64(9):2978-2979. No abstract available.

PMID:
11674382
40.

Carcinoid tumor development in an intramedullary spinal cord mature teratoma.

Fan X, Turner JE, Turner TM, Elrod JP, Clough JA, Howell EI, Johnson MD.

AJNR Am J Neuroradiol. 2001 Oct;22(9):1778-81. Review.

41.

Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury.

Sumner DR, Turner TM, Urban RM, Leven RM, Hawkins M, Nichols EH, McPherson JM, Galante JO.

J Orthop Res. 2001 Jan;19(1):85-94.

42.

Synthesis and preliminary analysis of a P-glycoprotein-specific [3H]-benzophenone photoaffinity label based on (-)-stipiamide.

Andrus MB, Turner TM, Sauna ZE, Ambudkar SV.

Bioorg Med Chem Lett. 2000 Oct 16;10(20):2275-8.

PMID:
11055337
43.
44.

Radiographic, biomechanical, and pathologic effects of hemoglobin glutamer-200 in dogs undergoing cemented total hip arthroplasty.

Braden TD, Tvedten HW, DeCamp CE, Turner TM, Hughes GS, Rentko VT.

Am J Vet Res. 1999 Nov;60(11):1337-40.

PMID:
10566804
45.

Functional adaptation and ingrowth of bone vary as a function of hip implant stiffness.

Sumner DR, Turner TM, Igloria R, Urban RM, Galante JO.

J Biomech. 1998 Oct;31(10):909-17.

PMID:
9840756
46.

Fluconazole disk diffusion susceptibility testing of Candida species.

Kirkpatrick WR, Turner TM, Fothergill AW, McCarthy DI, Redding SW, Rinaldi MG, Patterson TF.

J Clin Microbiol. 1998 Nov;36(11):3429-32.

48.

Unilateral hip replacement causes bilateral changes in tibial bone mineral content in a canine model.

Smith AM, Turner TM, Sumner DR.

J Bone Miner Res. 1996 May;11(5):693-6.

PMID:
9157785
49.

Enhancement of bone ingrowth by transforming growth factor-beta.

Sumner DR, Turner TM, Purchio AF, Gombotz WR, Urban RM, Galante JO.

J Bone Joint Surg Am. 1995 Aug;77(8):1135-47.

PMID:
7642657
50.

Bone ingrowth and wear debris in well-fixed cementless porous-coated tibial components removed from patients.

Sumner DR, Kienapfel H, Jacobs JJ, Urban RM, Turner TM, Galante JO.

J Arthroplasty. 1995 Apr;10(2):157-67.

PMID:
7798096

Supplemental Content

Loading ...
Support Center